Detalhe da pesquisa
1.
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.
J Thorac Oncol
; 10(10): 1437-43, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26295376